BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37944249)

  • 1. lncRNA HOXC-AS2 promotes the progression of hypopharyngeal cancer by binding to the P62 protein mediating the autophagy process.
    Xiang Y; Huang G; Wang J; Hua Q
    Aging (Albany NY); 2023 Nov; 15(21):12476-12496. PubMed ID: 37944249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOXC-AS2 mediates the proliferation, apoptosis, and migration of non-small cell lung cancer by combining with HOXC13 gene.
    Liu B; Li J; Li JM; Liu GY; Wang YS
    Cell Cycle; 2021 Jan; 20(2):236-246. PubMed ID: 33427025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of lncRNA HOXA-AS2 promotes the progression of oral squamous cell carcinoma by mediating SNX5 expression.
    Li Z
    BMC Mol Cell Biol; 2022 Dec; 23(1):59. PubMed ID: 36528556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of long non-coding RNA MALAT1 elevates microRNA-429 to suppress the progression of hypopharyngeal squamous cell carcinoma by reducing ZEB1.
    Liu X; Zhao W; Wang X
    Life Sci; 2020 Dec; 262():118480. PubMed ID: 32980391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA-HOXC-AS2 regulates tumor-associated macrophage polarization through the STAT1/SOCS1 and STAT1/CIITA pathways to promote the progression of non-small cell lung cancer.
    Yin C; Li J; Li S; Yang X; Lu Y; Wang C; Liu B
    Cell Signal; 2024 Mar; 115():111031. PubMed ID: 38168631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA XXYLT1-AS2 promotes tumor progression via autophagy inhibition through ubiquitinated degradation of TFEB in hepatocellular carcinoma.
    Li X; Wu Y; Wang P; Li Y; Gu J; Zhang Y; Yan S; Hu P
    Clin Transl Oncol; 2024 Mar; 26(3):698-708. PubMed ID: 37540409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
    Lin X; Ding JM; Zheng XZ; Chen JG
    Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA HOXC-AS1 exerts its oncogenic effects in esophageal squamous cell carcinoma by interaction with IGF2BP2 to stabilize SIRT1 expression.
    Yang Z; Wan J; Ma L; Li Z; Yang R; Yang H; Li J; Zhou F; Ming L
    J Clin Lab Anal; 2023 Jan; 37(1):e24801. PubMed ID: 36510377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RP11‑156L14.1 regulates SSR1 expression by competitively binding to miR‑548ao‑3p in hypopharyngeal squamous cell carcinoma.
    Yan J; Wang ZH; Yan Y; Luo HN; Ren XY; Li N; Zheng GX; Hou J
    Oncol Rep; 2020 Nov; 44(5):2080-2092. PubMed ID: 33000261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
    Zhang X; Niu W; Mu M; Hu S; Niu C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation a TGF-β-associated long non-coding RNA of head and neck squamous cell carcinoma by bioinformatics method.
    Huang T; Huang W; Lu H; Zhang BY; Ma J; Zhao D; Wang YJ; Yu DH; He X
    J Transl Med; 2018 Feb; 16(1):46. PubMed ID: 29490660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA HOXC-AS1 promotes gastric cancer via binding eIF4AIII by activating Wnt/β-catenin signaling.
    Zhou C; An N; Cao C; Wang G
    J Gene Med; 2020 Sep; 22(9):e3202. PubMed ID: 32307743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206.
    Xue K; Li J; Nan S; Zhao X; Xu C
    Life Sci; 2019 Aug; 231():116459. PubMed ID: 31075234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA ADAMTS9-AS2 promotes tongue squamous cell carcinoma proliferation, migration and EMT via the miR-600/EZH2 axis.
    Li Y; Wan Q; Wang W; Mai L; Sha L; Mashrah M; Lin Z; Pan C
    Biomed Pharmacother; 2019 Apr; 112():108719. PubMed ID: 30970517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Glucose-Induced Overexpression of HOXC-AS3 Promotes Metabolic Reprogramming of Breast Cancer.
    Zhu W; Chen X; Guo X; Liu H; Ma R; Wang Y; Liang Y; Sun Y; Wang M; Zhao R; Gao P
    Cancer Res; 2022 Mar; 82(5):805-818. PubMed ID: 35031573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive feedback loop of lncRNA HOXC-AS2/miR-876-5p/ZEB1 to regulate EMT in glioma.
    Dong N; Guo J; Han S; Bao L; Diao Y; Lin Z
    Onco Targets Ther; 2019; 12():7601-7609. PubMed ID: 31571911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA BANCR promotes oral squamous cell carcinoma progression via regulating Rab1A signaling.
    Li W; Xu X; Ma Z; Shen P; Cheng B; Xia J; Li Y
    J Oral Pathol Med; 2023 Sep; 52(8):727-737. PubMed ID: 37433101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HOXC-AS3 overexpression inhibits TGF-β2-induced colorectal cancer cell migration and invasion by sponging miR-1269.
    Zhang TT; Chen HP; Yu SY; Zhao SP
    Hum Exp Toxicol; 2022; 41():9603271221093630. PubMed ID: 35537198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA HOXA-AS2 promotes migration and invasion by acting as a ceRNA of miR-520c-3p in osteosarcoma cells.
    Wang Y; Zhang R; Cheng G; Xu R; Han X
    Cell Cycle; 2018; 17(13):1637-1648. PubMed ID: 30081707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA NFIA-AS2 promotes glioma progression through modulating the miR-655-3p/ZFX axis.
    Xin J; Zhao YH; Zhang XY; Tian LQ
    Hum Cell; 2020 Oct; 33(4):1273-1280. PubMed ID: 32779154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.